Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

One Or Multiple Investigational Sites, Japan Clinical Trials

A listing of One Or Multiple Investigational Sites, Japan clinical trials actively recruiting patients volunteers.

RESULTS

Found (3691) clinical trials

Dr. Kevin Black will look at the safety and effectiveness of an investigational drug compared to placebo (inactive substance) in the treatment of Parkinson’s disease with psychosis. Participation in this study may last up to 12 weeks. There will be a screening visit lasting about 3 hours and up to ...

Phase

The objective of this study is to evaluate the safety and efficacy of up to 26 weeks of treatment with calcitriol 3 mcg/g ointment when used twice daily, without occlusion, to treat pediatric subjects (2 to 17 years of age) with mild to moderate plaque psoriasis.

Phase

The purpose of this study is to evaluate the safety of using the Apollo™ micro catheter with a detachable tip to deliver Onyx™ LES liquid embolic agent into AVMs. The study will evaluate the performance of the Apollo™ Onyx™ Delivery Micro Catheter (Apollo™ Device) to deliver Onyx™ LES to brain ...

Phase

The purpose of this prospective parallel-cohort study in patients with relapsing forms of MS, either newly treated with fingolimod or receiving another disease-modifying therapy, is to further monitor the overall safety profile of fingolimod under conditions of routine medical practice and to explore the incidence of selected safety related outcomes. ...

Phase

The Pipeline™ device has been commercialized in the US since 2011 for the endovascular treatment of adults with large (≥ 10 - 24 mm) or giant (≥ 25 mm) wide-necked IAs in the ICA from the petrous to the superior hypophyseal segments. Over this period of time, additional long-term data ...

Phase

The study is trying to understand what causes bipolar disorder and how medications treat bipolar depression. If you participate, you will have two different brain scans (an MRI and a PET scan) and antidepressant treatment for free. We will then be able to see whether information on the brain scans ...

Phase

This is a randomized, placebo controlled, double blind study. Following a screening period of up to 28 days, subjects with active systemic lupus erythematosus (SLE) including moderate to severe rash and/or arthritis despite corticosteroid therapy will be randomized in a 1:1 ratio to receive 1 mL (80 Units [U]) of ...

Phase

This long-term follow up study will enroll subjects who will be transferred from selected interventional, company sponsored trials with radium-223 dichloride (feeder trials). The primary objectives are to define the long term safety profile of radium-223 dichloride (for up to 7 years after the last dose of radium-223 dichloride); to ...

Phase

Subjects with RRMS who have experienced a relapse and who will receive 3 to 5 (given over a period of up to 7 days) days of treatment with high dose steroids (oral or IV) within 10 days of the onset of relapse symptoms are candidates for the current study. At ...

Phase